Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Impact of different post-remission strategies on quality of life in patients with acute myeloid leukemia.

Impact of different post-remission strategies on quality of life in patients with acute myeloid leukemia. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Impact of different post-remission strategies on quality of life in patients with acute myeloid leukemia. Abstract Text:

    BACKGROUND: The impact on quality of life of allogeneic stem cell transplantation or conventional chemotherapy in patients with acute myeloid leukemia remains unclear, mainly because of a lack of studies with long-term follow-up. The German AML-Intergroup, therefore, initiated a survey on quality of life of patients with a relapse-free survival of at least 5 years after first-line treatment. DESIGN AND METHODS: The EORTC Quality of Life Core Questionnaire (QLQ-C30), supplemented by information on self-assessed concomitant diseases, late treatment effects, and demographics was used. The questionnaire was returned by 419 of 818 patients (51.2%) identified by six study groups. The patients' median age at diagnosis was 42 years, and the median follow-up period was 8 years. One hundred and seventy patients were treated with stem cell transplantation (121 allogenic, 49 autologous) in first complete remission; the other 249 patients were treated with conventional chemotherapy. RESULTS: The ECOG activity index revealed normal activity in 45% vs. 60% of the patients in the allogeneic stem cell transplantation vs. conventional chemotherapy groups, respectively and disabled person status in 60% vs. 35%. All QLQ-C30 functions, except physical functioning and pain, were poorer in allogeneic stem cell transplantation patients. Problems in leisure-time activities, social life, and financial management, sexual limitations and adverse effects were significantly more frequent in patients after allogeneic stem cell transplantation than after conventional chemotherapy. Multivariate logistic regression models on global health status revealed concomitant disease, age > 45 years, and allogeneic stem cell transplantation as significant risk factors. CONCLUSIONS: These results indicate that, compared to conventional chemotherapy, allogeneic stem cell transplantation has a significantly worse long-term impact on quality of life. This needs to be considered when treatment options are discussed.

    Impact of different post-remission strategies on quality of life in patients with acute myeloid leukemia. Publishing Authors By Initials

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Impact of different post-remission strategies on quality of life in patients with acute myeloid leukemia. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Haematologica

    VOLUME: 93

    Page Numbers: 826-33

    Journal Abbreviation: Haematologica

    ISSN: 1592-8721

    DAY: 10

    MONTH: 05

    YEAR: 2008

    Impact of different post-remission strategies on quality of life in patients with acute myeloid leukemia. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 417435

    Impact of different post-remission strategies on quality of life in patients with acute myeloid leukemia. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Impact of different post-remission strategies on quality of life in patients with acute myeloid leukemia. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Impact of different post-remission strategies on quality of life in patients with acute myeloid leukemia.

    AFFILIATION: Institut für Med. Informationsverarbeitung, Biometrie und Epidemiologie der Universität München (IBE), Marchioninistr. 15, D-81377 München, Germany. dorle@messerer.info

    Country: Italy

    Italy Research PublicationItaly Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Haematologica

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Impact of different post-remission strategies on quality of life in patients with acute myeloid leukemia Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News